retinal tissues
HRMECs
other disease animal model
ceRNA regulation (promotes); angiogenesis (promotes); mitochondrial function (inhibits); inflammation (promotes); apoptosis (promotes); proliferation (promotes); other pathway/process (promotes)
Bioinformatics Analysis; RNase R Treatment; Actinomycin D / DRB Stability Assay; Back-Splice Junction PCR / divergent primers PCR; RT-qPCR; Transfection; CCK8; Flow Cytometry(Non-apoptosis/cycle); Annexin V/PI Flow Cytometry; ELISA; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Western Blot; Tube Formation Assay; In Vivo Animal Model; H&E Staining; IF (Immunofluorescence)
-
hsa_circ_0099682 is a pro-pathogenic circRNA in diabetic retinopathy models. It acts as a cytoplasmic ceRNA that sponges miR-125b-5p, derepresses HNRNPU, and promotes mitochondrial dysfunction, inflammation, oxidative stress, apoptosis, and pathological neoangiogenesis. Silencing hsa_circ_0099682 protects HG-injured HRMECs and improves retinal pathology in STZ-induced DR rats.
0.7924
hsa_circ_0099682 exacerbates the development of diabetic retinopathy by promoting pathological neoangiogenesis via the miR-125b-5p/HNRNPU axis.
biological research